SAN DIEGO -- Lung cancer is the most commonly diagnosed cancer in the United States and often the most fatal unless caught early, but scientists are working on ways to improve their understanding of the disease.
Several hundred of scientists will gather in San Diego at the San Diego Marriott Marquis & Marina during Jan. 8-11, 2012, for the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine.
The conference is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.
Media are welcome to attend the conference and can register by contacting Jeremy Moore at Jeremy.Moore@aacr.org.
The conference will host a media briefing, entitled "Lung Cancer Diagnosis: Pitfalls, Challenges and the Path Ahead," on Tuesday, Jan. 10 at 1:00 p.m. PT (4:00 p.m. ET). The briefing will be held in the Atlanta/Chicago room of the San Diego Marriott Marquis & Marina.
The following leaders in lung cancer are scheduled to speak at the press conference:
- Roy Herbst, M.D., Ph.D., chief of medical oncology and associate director for translational research at the Yale Cancer Center;
- David P. Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research, director of the Specialized Program of Research Excellence in Lung Cancer and co-leader of the Thoracic/Head and Neck Research Program at the Vanderbilt-Ingram Cancer Center; and
- Paul A. Bunn, M.D., professor and James Dudley chair in cancer research at the University of Colorado School of Medicine.
Reporters who cannot attend in person can participate using the following information:
U.S./Canada (Toll Free): 888-647-7462
International (Toll): 201-604-0169
Conference leaders have also designated the following research as newsworthy:
Related biology news :1
- Estrogen-Targeting Drug Combo May Help Prevent Lung Cancer
Researchers Map Potential Genetic Origins, Pathways of Lung Cancer in Never-Smokers
- Ganetespib Showed Activity in KRAS-Mutant NSCLC as Monotherapy and in Combinations
- Precancer Markers Identified in Airway Epithelium Cells of Healthy Smokers
- Sorafenib Effective in Patients With Non-Small Cell Lung Cancer, but Low Survival Rates Reported
- Sensitive Detection Method Analyzes Circulating Tumor Cells in Patients With Lung Cancer
- Genetic Composition of Multicentric Lung Tumors Appears to be Similar
. MU researchers photoacoustic device finds cancer cells before they become tumors2
. New stage in fighting pancreatic cancer3
. Gene identified in increasing pancreatic cancer risk4
. Cleveland Clinic researcher discovers genetic cause of thyroid cancer5
. Penn engineers develop more effective MRI contrast agent for cancer detection6
. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers7
. Potential anti-cancer treatment method wins Kaye Award8
. Wayne State study finds soybean compounds enhances effects of cancer radiotherapy9
. Cancer from fetal exposure to carcinogens depends on dose, timing10
. AACR & IASLC to host molecular origins of lung cancer conference11
. London researchers lead innovative new cancer treatment study